Zelboraf (vemurafenib)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) May 2016 WARNINGS AND PRECAUTIONS Radiation Sensitization and Radiation Recall subsequent to vemurafenib treatment.. Fatal cases...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts